Breadcrumb
NIH Guide: Weekly Index for December 1, 2023
Weekly NIH Funding Opportunities and Notices
December 1, 2023
General Notices
-
Notice of Pre-Application Webinar for NOT-AG-23-060, "Notice of Special Interest (NOSI): Telehealth for People and Families Living with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)"
(NOT-AG-23-073)National Institute on Aging
-
Notice of Informational Webinar on the NIGMS G-RISE and IMSD Programs
(NOT-GM-24-016)National Institute of General Medical Sciences
-
Notice of NHLBI Participation in NOT-EY-23-009 "Notice of Special Interest (NOSI): Quantum Sensing in Biomedical Applications (SBIR/STTR)"
(NOT-HL-23-121)National Heart, Lung, and Blood Institute
-
Notice of Information: NIMH List of Human Genes Having Rare Variants with Strong Statistical Support for Association to Mental Health Traits
(NOT-MH-24-370)National Institute of Mental Health
-
Technical Assistance Webinars for RFA-NS-24-029 Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)"
(NOT-NS-24-036)National Institute of Neurological Disorders and Stroke
-
Notice of Correction to the Assistance Listing Number(s) for RFA-OD-23-017 "Tobacco Regulatory Science (R01 Clinical Trial Optional)"
(NOT-OD-24-030)Office of Disease Prevention
-
Request for Information on Themes for the NIAMS Strategic Plan for Fiscal Years 2025-2029
(NOT-AR-23-022)National Institute of Arthritis and Musculoskeletal and Skin Diseases
Notice of Changes to Funding Opportunities
-
Notice of Change to Key Dates Listed in RFA-AG-24-030, "Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional)"
(NOT-AG-23-074)National Institute on Aging
-
Notice of Change to Key Dates for PAR-23-308, Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
(NOT-CA-24-011)National Cancer Institute
-
Notice of Extension of the Expiration Date for PAR-21-290 "Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)"
(NOT-CA-24-012)National Cancer Institute
-
Notice of Correction to Expiration Date for PAR-24-045, "Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)"
(NOT-DC-24-008)National Institute on Deafness and Other Communication Disorders
-
Notice of Change: Extension of PAR-22-030 "Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)" by one Council Round
(NOT-NS-24-020)National Institute of Neurological Disorders and Stroke
-
Notice of Change: Extension of PAR-22-028 "Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)" by one Council Round
(NOT-NS-24-035)National Institute of Neurological Disorders and Stroke
-
Notice of Change: Extension of PAR-21-224 "NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)"
(NOT-NS-24-037)National Institute of Neurological Disorders and Stroke
Notices of Intent to Publish
Notices of Special Interest
-
Notice of Special Interest (NOSI): Development and Application of Novel Chemical Approaches to Discover Therapeutic Targets for Substance Use Disorders
(NOT-DA-25-027)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Data Informed, Place-Based Community-Engaged Research to Advance Health Equity
(NOT-HL-23-110)National Heart, Lung, and Blood InstituteNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Institute of Mental HealthNational Institute of Nursing ResearchOffice of Research on Women's HealthOffice of Behavioral and Social Sciences ResearchOffice of Disease PreventionNational Institute on Minority Health and Health Disparities
-
Notice of Special Interest (NOSI): SBIR/STTR Program Priorities to Bridge Gaps in Advancing the NIMH Mission
(NOT-MH-24-110)National Institute of Mental Health
-
Notice of Special Interest (NOSI): SBIR/STTR High-Priority Areas for Digital Mental Health Innovations
(NOT-MH-24-120)National Institute of Mental Health
Funding Opportunities
-
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
(PAR-23-311)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)
(PAR-24-041)National Institute of General Medical SciencesApplication Receipt Date(s): July 8, 2026
-
NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
(PAR-24-044)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)
(PAR-24-048)National Institute on Drug AbuseNational Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): November 13, 2026
-
NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)
(PAR-24-066)National Eye InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)
(PAR-24-071)National Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): September 25, 2026
-
Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)
(PAR-24-077)National Institute on Minority Health and Health DisparitiesNational Institute on Alcohol Abuse and AlcoholismNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Diabetes and Digestive and Kidney DiseasesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Complementary and Integrative HealthOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): Multiple dates, see announcement.
-
Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)
(RFA-AG-25-006)National Institute on AgingApplication Receipt Date(s): February 14, 2024
-
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
(RFA-CA-24-008)National Cancer InstituteApplication Receipt Date(s): October 1, 2024
-
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
(RFA-CA-24-009)National Cancer InstituteApplication Receipt Date(s): October 1, 2024
-
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
(RFA-CA-24-010)National Cancer InstituteApplication Receipt Date(s): October 1, 2024
-
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
(RFA-CA-24-011)National Cancer InstituteApplication Receipt Date(s): October 1, 2024
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
(RFA-CA-24-012)National Cancer InstituteApplication Receipt Date(s): October 1, 2024
-
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
(RFA-CA-24-013)National Cancer InstituteApplication Receipt Date(s): October 1, 2024
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
(RFA-CA-24-014)National Cancer InstituteApplication Receipt Date(s): October 1, 2024
-
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P30 Clinical Trial Optional)
(RFA-CA-24-015)National Cancer InstituteApplication Receipt Date(s): October 1, 2024
-
BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Optional)
(RFA-DA-24-042)National Institute on Drug AbuseNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): February 15, 2024
-
Cardiovascular Repository Type 1 Diabetes (CARE-T1D) Consortium (U01 Clinical Trial Not Allowed).
(RFA-DK-23-021)National Institute of Diabetes and Digestive and Kidney DiseasesNational Heart, Lung, and Blood InstituteApplication Receipt Date(s): April 11, 2024
-
Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)
(RFA-DK-25-001)National Institute of Diabetes and Digestive and Kidney DiseasesNational Heart, Lung, and Blood InstituteOffice of Research on Women's HealthApplication Receipt Date(s): September 2, 2024
-
Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed
(RFA-FD-24-007)Food and Drug AdministrationApplication Receipt Date(s): March 31, 2024
-
Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)
(RFA-HL-25-001)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): August 19, 2026
-
Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional)
(RFA-MH-24-105)National Institute of Mental HealthApplication Receipt Date(s): March 29, 2024
-
Early Psychosis Intervention Network (EPINET) Data Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-MH-24-106)National Institute of Mental HealthApplication Receipt Date(s): March 29, 2024
-
BRAIN Initiative: Marmoset Colonies for Neuroscience Research (U24 Clinical Trials Not Allowed)
(RFA-MH-25-115)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): March 1, 2024
-
BRAIN Initiative: Marmoset Coordination Center (U24 Clinical Trials Not Allowed)
(RFA-MH-25-116)National Institute of Mental HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): March 1, 2024
-
Short Courses to Promote the Broad and Rigorous Use of Common Fund Data (R25 Clinical Trial Not Allowed)
(RFA-RM-23-014)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): February 14, 2024
-
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
(RFA-TR-24-001)National Center for Advancing Translational SciencesNational Center for Advancing Translational SciencesApplication Receipt Date(s): March 15, 2024
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: February 15, 2025
For technical issues E-mail OER Webmaster